Rosenblatt downgrades Bullish stock rating on valuation concerns By Investing.com

Rosenblatt downgraded Bullish (BLSH) to Neutral from Buy, citing outperformance vs. peers and valuation concerns; the stock trades at $38.63 (market cap $5.81B) and ~28x consensus adjusted EBITDA, a premium to peers. Bullish reported March 2026 digital-asset trading volume of $60.4B (spot $52.9B; BTC $29.1B, ETH $8.0B) and 50% revenue growth over the last 12 months, while shares are down ~42% over six months and 2% YTD. Other analyst actions: Canaccord reiterates Buy with $50 PT, JPMorgan PT $42 (Neutral) with Q4 2025 adj. EPS est. $0.15 and adj. EBITDA $38M; Rosenblatt cut PTs (noted $39 and $52 in the article) and flagged collapsing crypto activity and fading IPO-related non-trading revenue tailwinds.

Analysis

BLSH is trading like a growth optionality rather than a near-term cash-flow story; that makes it highly sensitive to episodic supply shocks (lock‑up expiries, insider selling) and short-term volume volatility. A concentrated narrative premium amplifies downside if macro crypto flows reverse — expect 20–40% realized drawdowns on headline negative events within a 0–3 month window.

The firm's non-exchange growth vectors (options, stablecoin, U.S. expansion) have asymmetric execution risk: they can re-rate margins quickly if they scale, but they also consume capital and invite regulatory scrutiny that can truncate revenue visibility. Stablecoin or custody regulatory action would compress non-trading revenue and could cause immediate order-book and market‑making withdrawal, cutting liquidity and fees in weeks rather than quarters.

Second-order winners from a BLSH derating are incumbent U.S. exchanges and custody providers with deeper regulatory footprints and established institutional channels — they will pick up market share and flow-driven fee pools if BLSH volumes retrench. Market-makers and derivatives LPs will reprice spreads and collateral demands, which will further depress retail volumes at the weaker venue and accelerate the rotation.

Near-term catalysts to watch: lock‑up expiration (0–3 months), quarterly adjusted EBITDA prints and guidance (next 1–2 quarters), and a sustained >25% move in Bitcoin over 3 months which would validate growth optionality. Reversal risks include clearer U.S. regulatory approval for their products or a persistent BTC rally that restores fee volumes; both would justify a rapid re-rating within 3–12 months.

Key Decisions for Investors

• Tactical short BLSH: establish a 1–2% NAV short position or buy 3-month put options (≈25% OTM) ahead of lock‑up expiry; target 30–40% downside, set a hard stop at 20% adverse move. Rationale: forced supply + narrative premium; time horizon 0–3 months.
• Protect crypto exposure: purchase a 120-day put spread on BLSH sized to cover ~33% of directional crypto exposure (buy ATM put, sell 30–40% OTM put). Cost-efficient hedge that limits tails from regulatory/stablecoin shocks while capping premium paid.
• Relative pair trade (3–12 months): go long a large-cap, US-regulated exchange (e.g., COIN) and short BLSH at a 1:1 notional ratio (or 1.5x long COIN / 1x short BLSH) to capture rotation from narrative to regulated-fundamentals. Target 25–50% relative outperformance; tighten if spread narrows by 15%.
• Long asymmetric optionality (contrarian): if Bitcoin rallies >25% over any 3-month period or BLSH posts a meaningful EBITDA/guidance beat, deploy a small (0.5% NAV) 9-month call spread on BLSH to capture a rapid re-rating with defined downside. Expected skewed pay-off >3:1 if catalysts hit.